Back
Verve Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65
VERV
Verve Therapeutics
Last Price:
$10.96
Seasonality Move:
1.05%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERV is experiencing selling pressure, which indicates risk of future bearish movement.
Verve Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.04 | Sell |
20-day SMA: | 11.14 | Sell |
50-day SMA: | 7.54 | Buy |
200-day SMA: | 6.28 | Buy |
8-day EMA: | 9.54 | Buy |
20-day EMA: | 6.08 | Buy |
50-day EMA: | 3.02 | Buy |
200-day EMA: | 0.85 | Buy |
Verve Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.05 | Buy |
Relative Strength Index (14 RSI): | 74.78 | Buy |
Chaikin Money Flow: | -3363627 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.58 - 12.16) | Buy |
Bollinger Bands (100): | (3.86 - 9.04) | Buy |
Verve Therapeutics Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Verve Therapeutics Stock
Is Verve Therapeutics Stock a Buy?
-
Verve Therapeutics share price is 10.95 while VERV 8-day simple moving average is 11.04, which is a Sell signal.
-
The stock price of VERV is 10.95 while Verve Therapeutics 20-day SMA is 11.14, which makes it a Sell.
-
Verve Therapeutics 50-day simple moving average is 7.54 while VERV share price is 10.95, making it a Buy technically.
-
VERV stock price is 10.95 and Verve Therapeutics 200-day simple moving average is 6.28, creating a Buy signal.
VERV Technical Analysis vs Fundamental Analysis
Buy
65
Verve Therapeutics (VERV)
is a Buy
Is Verve Therapeutics a Buy or a Sell?
-
Verve Therapeutics stock is rated a BuyThe current Verve Therapeutics [VERV] share price is $10.95. The Score for VERV is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Verve Therapeutics Stock Info
Market Cap:
976.1M
Price in USD:
10.95
Share Volume:
5.6M
Verve Therapeutics 52-Week Range
52-Week High:
11.41
52-Week Low:
2.86
Buy
65
Verve Therapeutics (VERV)
is a Buy
Verve Therapeutics Share Price Forecast
-
What is the Verve Therapeutics stock price today?The Verve Therapeutics stock price is 10.95 USD today.
-
Will VERV stock go up or go down?Verve Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Verve Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verve Therapeutics is not overvalued.
Is Verve Therapeutics Stock a Buy?
-
Verve Therapeutics share price is 10.95 while VERV 8-day exponential moving average is 9.54, which is a Buy signal.
-
The stock price of VERV is 10.95 while Verve Therapeutics 20-day EMA is 6.08, which makes it a Buy.
-
Verve Therapeutics 50-day exponential moving average is 3.02 while VERV share price is 10.95, making it a Buy technically.
-
VERV stock price is 10.95 and Verve Therapeutics 200-day simple moving average is 0.85, creating a Buy signal.
Fundamental Analysis of Verve Therapeutics
Is Verve Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.36 per share.
Technical Analysis of Verve Therapeutics
Should I short Verve Therapeutics stock?
-
VERV Moving Average Covergence Divergence (MACD) indicator is 3.05, suggesting Verve Therapeutics is a Buy
-
Verve Therapeutics Relative Strength Index (RSI) is 74.78, which suggest Verve Therapeutics is overbought
-
The Bollinger Bands (25) for Verve Therapeutics is (8.58 - 12.16), which suggest Verve Therapeutics is a Buy
-
The Bollinger Bands (100) for Verve Therapeutics is (3.86 - 9.04), which suggest Verve Therapeutics is a Buy
* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.